Thomas Lingelbach, Valneva CEO

Covid-19 roundup: Man­u­fac­tur­ing con­tract axed for Val­ne­va’s vac­cine; Pen­ny stock halts ear­ly in­fec­tion tri­al

French vac­cine com­pa­ny Val­ne­va and Ger­man CD­MO IDT Bi­ologi­ka have de­cid­ed to ter­mi­nate their man­u­fac­tur­ing col­lab­o­ra­tion for Val­ne­va’s Covid-19 vac­cine.

IDT Bi­ologi­ka was orig­i­nal­ly tasked …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.